The rapidly emerging field of stem cell therapy has furthered the burgeoning area of regenerative medicine, with stem cell-based methods demonstrating proven success in reducing amounts of scarred heart tissue post-heart attack, and producing insulin-secreting cells in patients with type 1 diabetes.
Stem cell therapy, a critical segment of the regenerative medicine field and market, is a quickly evolving field, with the potential to help people heal more rapidly, in addition to avoiding invasive surgical procedures and treatments.
The ability of the body to heal itself through this therapy is derived from immature, self-renewing cells located in the body’s bone marrow, which can ultimately restore and repair a wide variety of bodily tissues. The NIH has awarded a $5.2 million grant to researchers who have collaborated to explore mechanisms of lung regeneration in diseases like cystic fibrosis.
Scientists have also recently found that a specific type of stem cell can generate a range of benefits for regenerative medicine, as they can be differentiated into multiple cell types including neurons, heart, pancreatic, and liver cells. These studies have further confirmed that stem cell therapy can treat neurodegenerative diseases, including Parkinson’s and other conditions.
This rapidly growing sector offers physicians, pharmaceutical and biotechnology companies, and medical professionals an opportunity to transition towards a more therapeutic approach. In areas where current treatment options such as surgery and pharmaceuticals are not effective, stem cell therapy offers a promising prospect of hope.
Learn more about stem cell therapy and its applications in regenerative medicine. The Fellowship in Stem Cell Therapies offers a comprehensive overview of relevant diseases, current research, and best practices for in-office applications.